#GLP-1 — FinScans

📈 Stocks

Novo Holdings Opens Obesity Drug Incubators Across Europe to Boost Weight-Loss Pipeline

June 19, 2026 (28 days ago)

Novo Holdings launches Europe-wide obesity drug incubators to strengthen Novo Nordisk's weight-loss R&D and challenge rivals in the booming GLP-1 market.

NVO LLY

🌍 EU Read More →

📈 Stocks

Bernstein Downgrades Packaged Food Stocks Amid Inflation, GLP-1 Impact

June 5, 2026 (42 days ago)

Bernstein downgrades packaged food stocks as inflation squeezes margins and GLP-1 drugs curb food consumption, hitting consumer staples ETFs like XLP.

XLP

🌍 US Read More →

🌐 Macro

Novo Nordisk’s Stock Swings Rattle Denmark’s Economy as Growth Fears Mount

May 29, 2026 (49 days ago)

Novo Nordisk’s market dominance ties Denmark’s economic fate to its stock performance, with recent downturns casting a shadow over the nation’s growth…

NVO OMXC25 EUR/DKK +1

🌍 DK Read More →

📈 Stocks

Novo, Lilly Brace for Ozempic Patent Expirations, Seek Next Blockbuster

May 28, 2026 (50 days ago)

Novo Nordisk and Eli Lilly stocks come under scrutiny as impending Ozempic and Mounjaro patent expirations threaten the GLP-1 revenue stream, forcing…

NVO LLY